For example, in a mouse model of triple-negative breast cancer showed that RT combined with anti-CTLA4 controlled both primary and metastatic tumors via tumor-infiltrating CD8+ T cells with a diverse TCR repertoire (61). The gene discussed is CD8A; the disease is neoplasm.